ReDrugBC
Novel therapeutic approaches, based on drug repurposing, for high risk non muscle invasive bladder cancer driven by patients’ proteomic signatures
CONTACT
Dr. Marika Mokou
Biologist, MSc, PhD
mosaiques-diagnostics GmbH
Rotenburger Straße 20
D-30659 Hannover, GERMANY
Phone: +49 (0)511 55 47 44 37
e-mail: mokou@mosaiques-diagnostics.com
Disclaimer
The website has been created to provide an overview of the MSCA Individual Fellowship program funded by the European Commission, called ReDrugBC.
The information is provided by the MSCA fellow and the Host Institution.
The content of the website is for general information purposes only.
We take the necessary steps to keep the information correct and up-to-date.
Every effort is made to keep the website up and running smoothly. However, our team takes no responsibility and accepts no liability for the website being temporarily unavailable due to technical issues beyond our control.
Webdesign/Administration
Dr. Nadine Mänz
Public Relations
mosaiques diagnostics GmbH
Rotenburger Str. 20
30659 Hannover
Germany
Phone +49 511 554 744 27
e-mail: maenz@mosaiques-diagnostics.com
Copyrights:
© The copyright lies with the respective authors of the content.
2022©
ReDrugBC is a Marie Sklodowska Curie Actions (MSCA) Individual Fellowship programme funded by the European Commission (H2020-MSCA-IF-2019, Grant agreement ID: 898260).